Nazivin (oxymetazoline) nose drops 0.01% 5 ml. vial

$12.00

Acute respiratory diseases accompanied by nasal congestion. Allergic rhinitis. Vasomotor rhinitis. To restore drainage and nasal breathing in diseases of the paranasal sinuses of the nasal cavity, Eustachian. To eliminate edema before diagnostic manipulations in the nasal passages.

Category:

Description

Nazivin composition
active substance: oxymetazoline;
1 ml of a solution of 0.01% contains oxymetazoline hydrochloride 0.1 mg;
excipients: citric acid, monohydrate; sodium citrate; glycerin (85%); purified water.

Dosage form
Nasal drops.

Pharmacological properties
These are baby nose drops. The active ingredient excites alpha-adrenergic receptors. When applied to the mucous membrane, it causes vasoconstriction, while reducing edema and redness. With rhinitis (runny nose), relieves nasal breathing.

Indications
Nazivin is used for swelling of the nasal mucosa due to colds, attacks of a cold with a large amount of liquid mucous secretions (vasomotor rhinitis), as well as allergic rhinitis, acute sinusitis.
In addition, it is indicated for acute otitis media (to restore the patency of the Eustachian tube).
It is also used to facilitate rhinoscopy.

Contraindications:

  • with allergies to the components of the solution;
  • with “dry” inflammation of the nasal mucosa with the formation of crusts (dry rhinitis);
  • with a past transsphenoidal removal of the pituitary gland or any other surgical interventions with a history of exposure of the meninges;
  • with tachycardia;
  • with arterial hypertension;
  • with angina pectoris;
  • with severe atherosclerosis;
  • during pregnancy, breastfeeding;
  • with simultaneous treatment with MAOIs, tricyclic antidepressants.

Use with caution:

  • when treating MAOIs or other drugs with a hypertensive effect in the past;
  • with increased intraocular pressure, especially with angle-closure glaucoma;
  • with cardiovascular pathology;
  • with pheochromocytoma;
  • with metabolic disorders (for example, diabetes mellitus, hyperthyroidism);
  • with porphyria;
  • with prostatic hyperplasia.

Children
The drug is used in children from birth.

Application during pregnancy and lactation
During these periods, Nazivin is not used.

Method of administration and dosage
Nazivin is applied intranasally (in the nose).
Kali is used in children from birth to 4 weeks – one drop in each nasal passage up to three times a day. Children from 5 weeks to a year – one or two drops in each nasal passage up to three times a day.
It is not recommended to use drops for more than five days.

Overdose
When applied topically, overdose is unlikely.
Symptoms: mydriasis (dilated pupils), nausea, cyanosis, convulsions, fever, cardiovascular disorders (tachycardia, arterial hypertension, arrhythmia, cardiac arrest), respiratory failure, changes in consciousness, drowsiness, pulmonary edema, decreased body temperature, bradycardia (decrease heart rate), a sharp drop in blood pressure, respiratory arrest, coma development.
Overdose treatment: stopping treatment, seeking medical attention immediately, intensive care.

Side effects:

  • Cardiovascular disorders: heart palpitations, arrhythmias, arterial hypertension.
  • Neurological disorders: headache, paroxysm, insomnia, fatigue, dizziness.
  • Respiratory, thoracic, mediastinal disorders: burning sensation in the nose, feeling of dryness, shortness of breath, sneezing, increased swelling of the nasal mucosa, epistaxis, atrophy of the nasal mucosa.
  • General disorders: tachyphylaxis, fatigue, drowsiness, visual impairment.
  • Digestive disorders: nausea.
  • Immune disorders: hypersensitivity reactions (angioedema, exanthema, itching).
  • Mental disorders: sleep disturbances, agitation, hallucinations.

Storage conditions and periods
Store Nazivin at a temperature of 15-25 ° C out of the reach of children. The shelf life of drops is two years, after opening the bottle – 6 months.